The FMR1 gene as regulator of ovarian recruitment and ovarian reserve

Obstetrical and Gynecological Survey

Volumn 65, Issue 8, 2010, Pages 523-530

  Gleicher, Norbert ^a,b   Barad, David H ^a,c  

^a Center for Human Reproduction (CHR) and Foundation for Reproductive Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MINOCYCLINE;

AGING; ALLELE; EARLY MENOPAUSE; ETHNICITY; FERTILITY; GENETIC COUNSELING; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; NEUROLOGY; NONHUMAN; OVARIAN RESERVE; OVARY FOLLICLE; OVARY FUNCTION; OVARY INSUFFICIENCY; PREMATURE OVARIAN FAILURE; PSYCHIATRIC DEPARTMENT; REVIEW; RNA TRANSLATION; TRINUCLEOTIDE REPEAT;

ALLELES; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; GENOTYPE; HUMANS; OVARIAN DISEASES; RISK; TRINUCLEOTIDE REPEATS;

EID: 78049407994     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3181f8bdda     Document Type: Review

References (50)

1. Wittenberger MD, Hagerman RJ, Sherman SL, et al. The FMR1 premutation and Reproduction. Fertil Steril 2007;87: 456-465.
2. Hagerman RJ, Hagerman PJ. Testing for fragile X mutations throughout the life span. JAMA 2008;300:2419-2421.
3. Verheij C, Bakker CA, de Graaff E, et al. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 1993;363:722-724. (Pubitemid 23227649)
4. Bassel GJ, Warren ST. Fragile X syndrome: loss of local mRNA regulation after synaptic development and function. Neuron 2008;60:201-214.
5. Ashley CT, Sutcliffe JS, Kunst CB, et al. Human and murie FMR-1: alternative spicing and translation initiation downstream of the CGG-repeat. Nat Genet 1993;4:244-251.
6. Wilson JA, Pratt VM, Phansalkar A, et al; the FragileXperts Working Group of the Association for Molecular Pathology Clinical Practice Committeee 2008. Consensus characterization of 16 FMR1 reference materials: a consortium study. J Molec Diagnost 10:2-12.
7. Oberle I, Russeau F, heitz D, et al. Instability of a 55-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991;252:1097-1102.
8. Naumann A, Hochstein N, Weber S, et al. A distinct DNA-methylation boundary in the 5'-upstream sequence of the FMR1 promoter binds nuclear proteins and is lost in fragile X syndrome. Am J Hum Genet 2009;85:606-616.
9. Allen EG, He W, Yadav-Shah M, et al. A study of the distribution characteristics of the FMR1 transcript levels in 238 individuals. Hum Genet 2004;114:439-447.
10. Hunter JE, Rohr JK, Sherman SL. Co-occuring diagnosis among FMR1 premutation allele carriers. Clin Genet 2010;77: 374-381.
11. Berman RF, Willemsen R. Mouse models of fragile x-associ-ated tremor ataxia. J Investig Med 2009;57:737-741.
12. Brouwer JR, Willemsen R, Oostra BA. The FMR1 gene and fragile X-associated tremor/ataxia syndrome. Am J Med Genet B Neuropsychiatr Genet 2009;150B:782-798.
13. Garcia-Alegria E, Ibañez B, Minguez M, et al. Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models. RNA 2007;13: 756-762.
14. Minguez M, Ibañez B, Ribate MP, et al. Risk of cognitive impairment in female premutation carriers of fragile X premutation: analysis by means of robust segmented linear regression model. Am J Med Genet B Neuropsychiatr Genet 2009; 150B:262-270.
15. Tassone F, Hagermann PJ. Expression of the FMR1 gene. Cytogenet Genome Res 2003;100:124-128.
16. Peprah E, He W, Allen E, et al. Examination of the FMR1 transcript and protein levels among premutation carriers. J Hum Genet 2009;55:66-68.
17. Bodega B, Bione S, Dalpra L, et al. Influence of intermediate and uninterrupted FMR1 CGG expansion in premature ovarian failure manifestation. Hum Reprod 2006;21:952-957.
18. Coffey SM, Cook K, Tartaglia N, et al. Expanded clinical phenotype of women with rhe FMR1 premutation. Am J Med Genet 2008;146A:1009-1016.
19. Hunter JE, Epstein MP, Tinker SW, et al. Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity. Genet Epidemiol 2008;32:553-559.
20. Tejada MI, Garcia-Alegria E, Bilbao A, et al. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile x syndrome. Menopause 2008;15:945-949.
21. Nelson LM. Clinical practice. Primary ovarian insuficiency. N Engl J Med 2009;360:606-614.
22. Barad DH, Weghofer A, Gleicher N. Age-specific levels of basal follicle-stimulating hormone assessment of ovarin function. Obstet Gynecol 2007;109:1404-1410.
23. Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005;117:376-382.
24. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Mullerian hormone. Fertil Steril 2009;91:1700-1706.
25. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil Steril 2009;91: 1707-1711.
26. Chatterjee S, Maitra A, Kadam S, et al. CGG repeat sizing in the FMR1 gene in Indian women with premature ovarian failure. Reprod Biomed Online 2009;19:281-286.
27. Streuli I, Fraisse T, Ibecheole V, et al. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril 2009;92:464-470.
28. Gleicher N, Weghofer A, Oktay K, et al. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)? Hum Reprod 2009;24:2395-2400.
29. Gleicher N, Weghofer A, Oktay K, et al. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test? Acta Obstet Gynecol Scand 2009;88:1024-1030.
30. Gleicher N, Weghofer A, Oktay K, et al. Can the FMR1 (fragile X) gene serve as predictor of response to ovarian stimulation? Reprod Sciences 2009;16:462-467.
31. Fu YH, Kuhl DP, Pizzuti A, et al. Variation of the CGG repeat of the fragile X site results in gene instability: resolution of the Sherman paradox. Cell 1991;67:1047-1058.
32. Chen LS, Tassone F, Sahota P. The (CGG)n repeat element within the 5' untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter. Hum Mol Genet 2003;12: 3067-3074.
33. Gleicher N, Weghofer A, Oktay K, et al. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod Biomed Online 2009;19:385-390.
34. Gleicher N, Weghofer A, Barad DH. Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors. Reprod Biomed Online 2010;20:485-491.
35. Gleicher N, Weghofer A, Barad DH. Ovarian reserve determinations suggest new function of FMR1 (fragile X) gene in regulating ovarian aging. Reprod Biomed Online 2010;20: 768-775.
36. Rohr J, Allen EG, Charen K, et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod 2008;23:1220-1225.
37. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 2002;124:601-609.
38. Weenen C, Laven JS, Von Bergh AR, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77-83.
39. Gleicher N, Weghofer A, Barad D. Too old for IVF: are we discriminating against older women? J Assist Reprod Genet 2007;24:639-644.
40. Kalberer U, Baud D, Fontanet A, et al. Birth records from Swiss married couples analyzed over the past 35 years reveal an aging of first-time mothers by 5.1 years while the inter-pregnancy interval has shortened. Fertil Steril 2009;92:2072-2073.
41. Bächner D, Manca A, Steinbach P, et al. Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests as special function in both the male and the female gonad. Hum Molec Genet 1993;2:2043-2050.
42. Hergersberg M, Matsuo K, Gassmann M, et al. Tissue-specific expression of FMR1/beta-galactosidase fusion gene in trans-genic mice. Hum Molec Genet 1995;4:359-366.
43. Yang L, Duan R, Chen D, et al. Fragile X mental retardation protein modulates fate of germline stem cells in drosophilia. Hum Mol Genet 2007;16:1814-1820.
44. Yang Y, Xu S, Xia L, et al. The bantam microRNA is associated with drosophilia fragile X mental retardation protein and regulates the fate of germline stem cells. PLoS Genet 2009;5: 31000444.
45. Epstein Am, Bauer CA, Ho A, et al. Drosophilia Fragile X protein controls cellular proliferation by regulating cbl levels in the ovary. Dev Biol 2009;330:89-92.
46. Pepper AS, Beerman RW, Bhogal B, et al. Argonaute2 suppresses Drosophilia fragile X expression preventing neuro-genesis and oogenesis defects, PLoS One 2009;4:e7618.
47. Rifé M, Nadal A, Milá M, et al. Immunohistochemical FMRP studies in a full mutated female fetus. Am J Med Genet A 2004;124A:129-132.
48. Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 2004;89:4569-4574.
49. Bilousova TV, Dansie L, Ngo M, et al. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 2009;46: 94-102.
50. Barad DH, Gupta A, Gleicher N. A slim PCOS-phenotype, characterized by heterozygous-normal/low genotype on the FMR1 (fragile X) gene. Hum Reprod. 2010;25 (Suppl 1):i82-83.